does glp 1 help with menopause symptoms GLP-1 Weight Loss in Menopause: How HRT Amplifies Results GLP-1 Agonists in Perimenopause: Unique
Description
Retatrutide, a novel triple receptor agonist targeting glucagon-like peptide-1 (GLP-1), Glucose-Dependent Insulinotropic Polypeptide ...

Clear role: high-efficacy anchor therapy with adherence advantages

Read highlights from the released 2025 Standards of Care, including recommendations for CGM use in type 2 diabetes for the first time, the use of GLP-1 drugs for kidney and heart benefits and a warning of DKA risk in recreational marijuana use.
Conclusions GLP-1 agonists are associated with significant pancreatitis risk which increases with larger cumulative doses.

Purpose of Review The development of long-acting incretin receptor agonists represents a significant advance in the fight against the concurrent epidemics of type 2 diabetes mellitus (T2DM) and obesity

Heres what to watch as this $40B+ category continues to grow.
